RK

Ranjan Kumar

Active Director Director DIN 08759909
DIN 08759909 First appointment Jun 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Ranjan Kumar

Data last updated:

Ranjan Kumar is a Director at Wingspan Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare. Wingspan Pharmaceuticals Private Limited reported revenue of ₹92.1 Lakh (FY 2024).

DIN 08759909
Primary Designation Director
Industry Healthcare
First Appointment 11 Jun 2020
Oldest Company Age 6 yrs
Largest company Wingspan Pharmaceuticals Private Limited · ₹92.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jun 20202020₹92.1 Lakh (FY 2024)Active

Board colleagues of Ranjan Kumar

Directorship timeline

Open interactive timeline →
Wingspan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ranjan Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjan Kumar

Ranjan Kumar currently holds 1 directorship: Wingspan Pharmaceuticals Private Limited (Director, since 11 Jun 2020, revenue ₹92.1 Lakh (FY 2024)).

Ranjan Kumar was first appointed on 11 Jun 2020 as Director at Wingspan Pharmaceuticals Private Limited.

The current boards of Ranjan Kumar's companies include Avinash Sharma (Wingspan Pharmaceuticals Private Limited), Renu Devi (Wingspan Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available